15 Years From Discovery To The Clinic

The total number of novel biomarkers that have come to market in new IVD tests cleared or approved by the FDA over the last 12 years has been very low; an average of just 3 per year*. Is this cause for alarm? At first glance one would assume yes, but the next factor...

“As I lay dying” – A Powerful Personal Exhortation

This moving opinion piece in the LA Times was just shared with me by Adam Carroll (our CSO and co-founder), which was written by a distinguished foreign correspondent, Laurie Becklund, who just died of breast cancer. In this piece Laurie lays a withering blow on...

Linking Data Silos is a Major Key to Clinical Genomics

Part of President Obama’s “precision medicine” initiative is the characterization of the genomes of one million American volunteers. The proposal includes characterizing several hundred thousand new participants, and connecting the data with genetic...

Huge Growth in New Biomarkers During 2014

The number of publications that describe studies involving new biomarkers increased significantly during 2014, with 37% more such studies in 2014 than 2013. This figure shows the total number of publications each year that include the words “novel...